PROSHARES ULTRA NASDAQ BIOTECH

Codice
BIB
Risorse esterne
Opinione della community
Prezzo Variazione Volume
42.21 -0.8 €
(-1.86%)
242342
P/E Obiettivo ad 1anno
0 0 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 9
Sell : 5

after

Commenti


Notizie

Wall Street Holds Inauguration Gains, How Did This Stock Fare: ProShares UltraShort Nasdaq Biotech (NASDAQ:BIS) - Wall Street Beacon

ProShares UltraShort Nasdaq Biotech (NASDAQ:BIS) closed at $32.65 after seeing 131054 shares trade hands during the most recent session. This represents a change of 1.18% from the opening. The closing price represents the final price that a stock is ...altro » Leggi

Average True Range Check on ProShares Ultra Nasdaq Biotechnology (BIB) - Sherwood Daily

Traders may be focusing in on the ATR or Average True Range indicator when performing stock analysis. At the time of writing, ProShares Ultra Nasdaq Biotechnology (BIB) has a 14-day ATR of 1.58. The average true range indicator was developed by J.altro » Leggi

Trump Sworn In as S&P Declined, How Did this Stock Perform This Week: ProShares UltraShort Nasdaq Biotech ... - Aiken Advocate

ProShares UltraShort Nasdaq Biotech (NASDAQ:BIS) performed nicely this week, continuing its impressive near-term upward movement. The stock has moved north 3.91% over the past week of trading. Looking further out, over the past twelve months, ...altro » Leggi

Williams %R Check on Shares of ProShares Ultra Nasdaq Biotechnology (BIB) - Springdale Times

Investors may be watching technical indicators such as the Williams Percent Range or Williams %R. ProShares Ultra Nasdaq Biotechnology (BIB)'s Williams %R presently stands at -50.28. The Williams %R is a momentum indicator that helps measure oversold ...altro » Leggi

Trump Foreshadows a Bleak Outlook for Biotech (IBB, BIB) - Investopedia

While biotechnology (biotech) stocks and exchange-traded funds (ETFs) briefly surged following President-elect Donald Trump's victory, these same securities have suffered declines in recent weeks after Trump took aim at companies in this industry ...altro » Leggi

Healthcare And Biotech ETFs Continue Recovery As Money Pours In - ETF Daily News (blog)

In fact, the largest “Healthcare” ETF is XLV (SPDR Health Care Select Sector, Expense Ratio 0.15%, $13.4 billion in AUM), and the fund has rallied in seven consecutive trading sessions now including today's, holding above its 200 day MA after having ... Leggi

Private Capital Advisors, Inc. Buys MPLX LP, Visa Inc, Applied Materials Inc, Sells Plains All American Pipeline LP ... - GuruFocus.com

New York, NY, based Investment company Private Capital Advisors, Inc. buys MPLX LP, Visa Inc, Applied Materials Inc, Blackstone Mortgage Trust Inc, Nike Inc, sells Plains All American Pipeline LP, Trillium Therapeutics Inc, Macrogenics Inc, ProShares ...altro » Leggi

​Volatility Could Pick Up During the First Half of 2017 - Equities.com

To gain exposure to these sectors that could experience a high degree of volatility within the coming weeks, investors could look to exchange-traded funds (ETFs) tracking those sectors. Here's a look at some sector ETFs that could move due to Trump and ... Leggi

4 Stocks To Watch: AKAO, CLVS, NRDM, SUPN - Investing.com

Achaogen Inc (NASDAQ:AKAO), one of our swing trades, finally popped out of the little coil we were watching, up 1.88, or 14 1/2%, to 14.88, on 2.9 million shares traded on Wednesday. ... Stocks on the long side included ACADIA Pharmaceuticals Inc ...altro » Leggi

Catalysts for a 2017 Biotech Bounce - ETF Trends

The iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), SPDR S&P Biotech ETF (NYSEArca: XBI) and other biotechnology exchange traded funds were punished last year with election year rhetoric widely seen as the primary catalyst behind the sector's ...altro » Leggi